Development of Fertility Regulation Methods by Small Business (R43/R44 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved non-hormonal contraceptive products for men and women.


  • Letter of Intent Due Date(s): June 30, 2020

  • Application Due Date(s): July 30, 2020

RFA-H?D-21-007 Expiration Date July 31, 2020

Agency Website

Eligibility Requirements

Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. 

Amount Description

Budgets up to $225,000 total costs per year for Phase I and up to $1,500,000 total costs per year for Phase II may be requested.

Funding Type





Engineering and Physical Sciences
Medical - Clinical Science
Medical - Translational

External Deadline

July 30, 2020